PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40121C00109Eo14042 strengthening pharmacovigilance systems — University of California, Los Angeles

University of California, Los Angeles holds $56.1M across 151 federal awards, concentrated at National Aeronautics and Space Administration (NASA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. PoP ended Sep 30, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs
Awarding office
University of California, Los Angeles
Recipient
Sep 30, 2026
PoP end
$0
Obligated
$2.8M
Potential
541714
NAICS
AN11
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40121C00109
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentUniversity of California, Los Angeles
CAGE4B557
UEIRN64EPNH8JC6
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAN11
Place of performanceSILVER SPRING MD
Pricing typeFirm Fixed Price
Extent competedFull And Open Competition
Related solicitationFDABAA-21-00123
PoP startAug 27, 2021
PoP end (current)Sep 30, 2026
Obligated$0
Current value$2.8M
Potential value$2.8M

EO14042 STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60 is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by University of California, Los Angeles. Estimated value $2.8M ($0 obligated). Current period of performance ends Sep 30, 2026. Last award drew 1 bidder. Place of performance: SILVER SPRING MD. Related solicitation FDABAA-21-00123.

EO14042 STRENGTHENING PHARMACOVIGILANCE SYSTEMS AND ADVERSE EVENTS REPORTING FOR MATERNAL IMMUNIZATION SAFETY IN THE DEMOCRATIC REPUBLIC OF CONGO - BAA GLOBWP 60

Recompete timing

Public
● Past PoP end (1 days ago)

Current PoP ended Sep 30, 2026 (1 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75F40121C00109? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

University of California, Los Angeles — $56.1M obligated across 151 awards (firm-wide, all agencies) · lead buyer National Aeronautics and Space Administration (NASA).

% of firm-wide obligated ($56.1M) · all agencies · Top 4 shown (95%); remaining ~5% is other agencies.
National Aeronautics and Space Administration (NASA)$23.9M · 43%Department of Health and Human Services (HHS)$21.6M · 39%Department of Defense (DOD)$4.3M · 8%Department of Veterans Affairs (VA)$3.3M · 6%
Open full company profile →

Related awards

Same incumbent
W912HQ23P0013
SERDP PROJECT: ER23-3775 A SYSTEMS APPROACH FOR THE ASSESSMENT AND PREDICTION OF THE NATUR…
$250K
Jan 23, 2027
75N95025P00457
DNA METHYLATION MICROARRAY PROCESSING SERVICES FOR THE BALTIMORE LONGITUDINAL STUDY OF AGI…
$331K
Sep 29, 2026
36C24E25N0282
ACADEMIC AFFILIATE - ANIMAL LAB & CORE SERVICES
$101K
Sep 28, 2026
W912HQ22C0086
SERDP PROJECT ER-2713 FOLLOW ON
$1.0M
Sep 27, 2026
36C24E25N0258
RESEARCH ASSISTANCE SERVICES
$195K
Sep 14, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40121C00109?

75F40121C00109 (Eo14042 strengthening pharmacovigilance systems) is a Fda Office Of Acq Grant Svcs award with a potential value of $2.8M, currently held by University of California, Los Angeles. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40121C00109?

Fda Office Of Acq Grant Svcs awarded 75F40121C00109 to University of California, Los Angeles (potential $2.8M).

Who is the incumbent on 75F40121C00109?

University of California, Los Angeles is the incumbent with $56.1M across 151 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does University of California, Los Angeles’s 75F40121C00109 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40121C00109? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40121C00109